Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genentech invests $125m in Oregon biologics manufacturing

This article was originally published in Scrip

Executive Summary

Genentech is to invest $125m to expand its fill/finish facility in Hillsboro, Oregon. The expansion will add up to 100 new skilled manufacturing jobs over the next five years. The site first opened in 2010, and houses a state of the art fill/finish facility and a warehouse and distribution center. The expansion is aimed at meeting growing demand for Genentech's biological products.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts